Sarah Cannon Development Innovations — Nashville, Tennessee

Sarah Cannon Development Innovations is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Development Innovations has participated in 1 clinical trials.

Therapeutic areas: Metastatic Melanoma and Other Solid Tumors.

Sponsors: Bayer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Development Innovations?

Sarah Cannon Development Innovations has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Development Innovations conducted?

Sarah Cannon Development Innovations has 1 clinical trials on record. Their work covers Metastatic Melanoma and Other Solid Tumors.

Is Sarah Cannon Development Innovations accredited by Crixeo Health?

Sarah Cannon Development Innovations has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Development Innovations?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.